FANTINI, FLAVIO
 Distribuzione geografica
Continente #
EU - Europa 4.633
NA - Nord America 3.797
AS - Asia 3.430
SA - Sud America 286
AF - Africa 92
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 12.242
Nazione #
US - Stati Uniti d'America 3.663
GB - Regno Unito 1.325
CN - Cina 1.147
SG - Singapore 1.135
IT - Italia 677
DE - Germania 621
FR - Francia 439
SE - Svezia 409
RU - Federazione Russa 342
UA - Ucraina 288
IN - India 237
HK - Hong Kong 233
VN - Vietnam 206
BR - Brasile 157
TR - Turchia 151
IE - Irlanda 138
EU - Europa 134
KR - Corea 129
NL - Olanda 111
CA - Canada 104
FI - Finlandia 97
CO - Colombia 73
GR - Grecia 63
BD - Bangladesh 47
CI - Costa d'Avorio 40
JP - Giappone 38
PL - Polonia 32
DK - Danimarca 20
AR - Argentina 17
UZ - Uzbekistan 16
BE - Belgio 15
IQ - Iraq 14
ID - Indonesia 13
PK - Pakistan 12
RO - Romania 12
ZA - Sudafrica 12
CZ - Repubblica Ceca 10
EC - Ecuador 10
MX - Messico 10
ES - Italia 8
VE - Venezuela 8
EG - Egitto 7
AE - Emirati Arabi Uniti 6
TN - Tunisia 6
KE - Kenya 5
MY - Malesia 5
UY - Uruguay 5
BO - Bolivia 4
CL - Cile 4
JO - Giordania 4
PE - Perù 4
PY - Paraguay 4
SA - Arabia Saudita 4
AT - Austria 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BS - Bahamas 3
CY - Cipro 3
HR - Croazia 3
IL - Israele 3
MA - Marocco 3
NG - Nigeria 3
NP - Nepal 3
PH - Filippine 3
TW - Taiwan 3
AL - Albania 2
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
CH - Svizzera 2
CR - Costa Rica 2
GA - Gabon 2
JM - Giamaica 2
KH - Cambogia 2
KW - Kuwait 2
MW - Malawi 2
PA - Panama 2
TT - Trinidad e Tobago 2
AU - Australia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
CG - Congo 1
CM - Camerun 1
CV - Capo Verde 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GL - Groenlandia 1
GM - Gambi 1
GN - Guinea 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LT - Lituania 1
Totale 12.355
Città #
Southend 1.170
Singapore 642
Ashburn 391
Chandler 324
Beijing 284
San Jose 262
Jacksonville 259
Hong Kong 207
Santa Clara 196
Milan 162
Princeton 159
Seattle 143
Dublin 136
Frankfurt am Main 132
Wilmington 125
Bengaluru 120
Redmond 115
Mountain View 110
Ann Arbor 102
Los Angeles 98
Serra 96
Toronto 90
Council Bluffs 84
Nanjing 82
Ho Chi Minh City 77
Bogotá 68
Dallas 68
Dearborn 67
Sakarya 66
Andover 65
Athens 62
Shanghai 61
Somerville 60
Lauterbourg 58
Boardman 55
Woodbridge 55
Moscow 47
Abidjan 40
Shenyang 40
Hanoi 39
Houston 38
New York 35
Des Moines 34
Jinan 33
Grafing 32
Berlin 31
Buffalo 30
Guangzhou 29
Changsha 27
Nanchang 27
Tokyo 27
Helsinki 26
Warsaw 25
Hebei 24
Rome 24
Bitonto 22
Cangzhou 22
Fairfield 22
Hefei 22
Tianjin 19
Orem 17
Kunming 16
Munich 16
Fuzhou 15
Saint Petersburg 15
Verona 15
Columbus 14
Hangzhou 14
Scranton 14
São Paulo 14
Kiez 13
Quanzhou 13
Taiyuan 13
Brussels 12
Falls Church 12
Nürnberg 12
Redwood City 12
Roxbury 12
The Dalles 12
Zhengzhou 12
A Shan 11
Auburn Hills 11
Bühl 11
Fremont 11
Norwalk 11
Phoenix 11
Shenzhen 11
Haiphong 10
Kent 10
Lanzhou 10
Ningbo 10
Baghdad 9
Chennai 9
Hanover 9
Pune 9
Brno 8
Dong Ket 8
Johannesburg 8
San Diego 8
Turin 8
Totale 7.432
Nome #
Anticorpi anti-peptide citrullinato ciclico in pazienti con artropatia sclerodermica 364
Activation of inflammation, coagulation and fibrinolysis in patients with Rheumatoid Arthritis : inhibition by Tumor Necrosis Factor alpha blockade 362
Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis : effects of tumor necrosis factor-alpha blockade 326
Cellule endoteliali circolanti quale marker diretto di danno endoteliale in corso di sclerosi sistemica 300
Evaluation of nailfold videocapillaroscopic abnormalities in patients with systemic lupus erythematosus 288
Un nuovo algoritmo prognostico basato su parametri capillaroscopici e autoanticorpali per identificare i soggetti con fenomeno di Raynaud a rischio di sviluppare sclerosi sistemica 288
Ruolo della videocapillaroscopia periungueale in pazienti con dermato/polimiosite idiopatica dell’adulto e infantile 277
Long-Term Evaluation (Efficacy and Safety) of Infliximab in the Treatment of Persistently Active Juvenile Idiopathic Arthritis (JIA), Refractory to Standard Treatments 259
IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors 255
Progenitori delle cellule endoteliali di origine midollare in corso di sclerosi sistemica: possibile ruolo nell’angiogenesi=Endothelial progenitor cells in systemic sclerosis: their possible role in angiogenesis 242
Comparative analysis of different indices of hand disability in systemic sclerosis 235
Trattamento con un dispositivo ortodontico per l’impegno temporomandibolare nell’artrite idiopatica giovanile. Osservazioni su 72 casi 232
Valutazione del dannno anatomico e funzionale della mano nei pazienti con sclerosi sistemica 231
Haemostatic and inflammatory biomarkers in patients with rheumatoid arthritis : effect of tumor necrosis factor alpha blockade 230
Effetto della terapia con infliximab sui marcatori di infiammazione, coagulazione e fibrinolisi nell’artrite reumatoide 229
Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis. 228
Bronchus-associated lymphoid tissue lymphoma in a patient with primary Sjögren's syndrome 227
Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder : PRINCE (prognostic index for nailfold capillaroscopic examination) 226
Systemic sclerosis, capillary leak syndrome and nasopharyngeal carcinoma : an unusual association or paraneoplastic manifestations? 215
Nailfold capillaroscopic report : qualitative and quantitative methods 210
Haemostatic and inflammatory biomarkers in patients with active Rheumatoid Arthritis : effects of Tumor Necrosis Factor alpha blockade 210
Anti-tumor necrosis factor alpha therapy normalizes fibrinolysis impairment in patients with active rheumatoid arthritis 208
Feasibility of different capillaroscopic measures for identifying nailfold microvascular alterations 206
Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy 203
Temporomandibular joint involvement in juvenile idiopathic arthritis : treatment with an orthodontic appliance 200
Diagnostic validity in detecting different capillaroscopic patterns by qualitative versus quantitative scoring methods 198
Effect of tumor necrosis factor alpha blockade on inflammatory and haemostatic biomarkers in patients with rheumatoid arthritis 196
Skeletal mineralization in a prepubertal female population affected by juvenile idiopathic arthritis 194
Evaluation of nailfold videocapillaroscopic abnormalities in patients with systemic lupus erythematosus 193
Reduction of haemostatic and inflammatory biomarkers by tumor necrosis factor-alpha bockade in patients with rheumatoid arthritis 188
A novel prognostic rule-based scheme for identifying Raynaud’s phenomenon patients at high risk for the development of systemic sclerosis using capillaroscopy and autoantibodies 188
Utility and reliability of different capillaroscopic measures for the identification of secondary Raynaud’s phenomenon 187
Bilateral vocal fold immobility in a patient with overlap syndrome rheumatoid arthritis/systemic sclerosis 185
Simultaneous ultrasonography and arthroscopy for the study of the joint environment: indications and limits 184
PRINCE: prognostic index for nailfold capillaroscopic examination for identifying raynaud's phenomenon at high risk of developing into a scleroderma spectrum disorder 184
Juvenile idiopathic arthritis in adulthood in a tertiary reference centre 182
Efficacy of a second TNFAlpha blocker when the first one failed in patients with juvenile idiopathic arthritis (JIA) treated with Infliximab, Etanercept and Adalimubab 181
Capillaroscopic observations in childhood rheumatic diseases and healthy controls 177
Reliability and validity of the Italian version of the hand functional disability scale in patients with systemic sclerosis 175
The effect of anti-TNF therapy on uveitis associated with juvenile idiopathic arthritis : the ten tear experience of our centre 173
A Comparison of Response Criteria in Patients with Juvenile Idiopathic Arthritis Treated with Methotrexate And/or Anti-Tnfα Agents 170
CHARACTERIZATION OF OSTEOCORTICAL-PERIOSTEAL LAYERS BY HIGH-RESOLUTION SONOGRAPHY USING A DOPPLER TECHNIQUE IN PAGET'S DISEASE OF BONE 170
Pregnancy outcome in women with inherited/acquired thrombophilia 168
Hand impairement in systemic sclerosis : a comparative analysis of different functional indices in a cross-sectional study 168
Treatment of active rheumatoid arthritis (RA) with combination therapy by adding leflunomide (LEF) in patients with an inadeguate response to methotrexate (mtx) 167
Chronic Recurrent Multifocal Osteomyelitis (CRMO) : four cases treated with Aminobisphosphonate (Pamidronate) 166
Side Effects of Anti-Tnfα Therapy in Jia, in an Open Monocentric Prospective Study of 151 Patients 160
Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis : results of an open-label prospective study 159
Anti-Cyclic Citrullinated Peptide Antibodies in Juvenile Idiopathic Arthritis (jia). A Monocentric Cross-Sectional Study 157
Monitoring therapeutic response by power doppler technique (PWD) of osteocortical-periosteal layers in a series of 31 patients with Paget's disease in standard treatment 157
Evaluation of cognitive dysfunction in patients with juvenile onset SLE 156
Distinct immune profiles characterize patients with diffuse or limited systemic sclerosis 155
Anakinra in systemic juvenile idiopathic arthritis (SOJIA) non responsive to anti-TNF 151
Focus on adverse events of tumour necrosis factor α blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients 149
Assessment of negative prognostic factors in patients affected by systemic sclerosis with cardiac involvement. A retrospective study 148
Primary antiphospolipid syndrome associated with small aorta syndrome: a case report. 146
Effectiveness and safety of leflunomide in the clinical practice : a different experience 144
Scleroderma-like pattern in patients with systemic lupus erythematosus (SLE): a red flag for overlap syndrome SLE/systemic sclerosis? 143
Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the literature and personal experience 141
The efficacy and cost effectiveness of iloprost in the treatment of systemic sclerosis: a comparative analysis 136
Evaluation by dual-photon absorptiometry of bone mineral loss in rheumatic children on long-term treatment with corticosteroids 136
Treatment of Severe Systemic Sclerosis (SSC) with autologous Haematopoietic Stem Cell Transplantation (HSCT): description of two cases 135
Disfunzione cognitiva nel LES ad insorgenza giovanile 134
Valutazione dei fattori prognostici negativi in pazienti affetti da sclerosi sistemica con coinvolgimento cardiaco: studio retrospettivo 133
About the difficulty in interpreting ultrasonographic images of temporomandibular joint 129
Potential effect of anti-tumour necrosis factor-alpha treatment on reducing the cardiovascular risk related to rheumatoid arthritis 126
Ruolo delle chemochine nella patogenesi della sinovite cronica in corso di artrite reumatoide [Role of chemokines in the pathogenesis of chronic synovitis during rheumatoid arthritis] 71
Totale 13.011
Categoria #
all - tutte 32.293
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.293


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021297 0 0 0 0 0 0 0 0 0 0 250 47
2021/2022614 61 13 12 7 25 19 90 32 110 59 62 124
2022/20231.028 148 96 70 175 108 218 16 55 97 6 30 9
2023/2024622 10 51 43 45 182 80 15 47 9 13 61 66
2024/20251.634 51 203 19 207 180 59 53 143 32 92 113 482
2025/20262.946 350 129 271 224 334 203 382 163 359 342 189 0
Totale 13.011